Protocol - Anxiety Disorders Symptoms - Adult
- Broad Psychopathology - Adult
- Broad Psychopathology - Child
- Emotional Distress
- General Well-being
- Intolerance of Uncertainty Scale (IUS)
- Positive and Negative Perfectionism Scale
- PTSD Screener - DSM 5
- PTSD Screener - DSM-IV
- PTSD Symptoms, Severity, and Diagnosis - DSM 5
- PTSD Symptoms, Severity, and Diagnosis - DSM-IV
- Quality of Life Enjoyment and Satisfaction - Adult
- Quality of Life Enjoyment and Satisfaction - Children
- Temperament and Character Inventory (TCI)
- Toronto Alexithymia Scale (TAS-20)
Description
This protocol includes the anxiety subscale of the Symptom Check List 90 (SCL-90). The anxiety subscale of the SCL-90 includes self-administered questions for adults that cover primary symptom dimensions and provide an overview of the respondent’s symptoms and their intensity at a specific point in time. Each item is scored on a scale of 0 to 4 (with 0 = not at all, 1 = a little bit, 2 = moderately, 3 = quite a bit, and 4 = extremely), asking respondents which number best describes how much that problem has bothered them in the last 4 weeks.
Specific Instructions
The Symptom Checklist 90 (SCL-90) is a proprietary, fee-based instrument that is available from Pearson Education, Inc.
Availability
Protocol
Symptom Assessment from the Symptom Check List 90
The Symptom Check List 90 is published and distributed exclusively by NCS Pearson, Inc., and can be obtained through:
Pearson
Attn: Customer Service
P.O. Box 599700
San Antonio, TX 78259
Telephone: 800.627.7271
Email: clinicalcustomersupport@pearson.com
Personnel and Training Required
None
Equipment Needs
None
Requirements
| Requirement Category | Required |
|---|---|
| Major equipment | No |
| Specialized training | No |
| Specialized requirements for biospecimen collection | No |
| Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adult, Senior, Pregnancy
Participants
An individual aged 13 and older with a 6th-grade reading level.
Selection Rationale
The Symptom Check List 90 (SCL-90) was selected to provide a quantitative measure of anxiety symptoms rather than simply categorical diagnoses. SCL-90 was vetted against several other dimensional measures of anxiety disorders and ultimately selected because it is easily administered as a self-reported instrument, takes less than 15 minutes, and captures general symptoms of anxiety.
Language
English, Other languages available at source
Standards
| Standard | Name | ID | Source |
|---|---|---|---|
| Human Phenotype Ontology | Anxiety | HP:0000739 | HPO |
Derived Variables
None
Process and Review
Expert Review Panel 4 (ERP 4) reviewed the measures in the Neurology, Psychiatric, and Psychosocial domains.
Guidance from ERP 4 includes the following:
- New Measure
Protocol Name from Source
Symptom Check List 90 (SCL-90)
Source
Derogatis, L. R, Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale-Preliminary report. Psychopharmacology Bulletin, 9(1), 13-28.
The Symptom Check List 90 (SCL-90) is published and distributed exclusively by NCS Pearson, Inc., and can be obtained through:
Pearson
Attn: Customer Service
P.O. Box 599700
San Antonio, TX 78259
Telephone: 800.627.7271
Email: clinicalcustomersupport@pearson.com
General References
American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
Dai, Y., Li, X., Zhang, X., Wang, S., Sang, J., Tian, X., & Cao, H. (2016). Prevalence and predisposing factors for depressive status in Chinese patients with obstructive sleep apnoea: A large-sample survey. PLoS ONE, 11(3), e0149939.
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62(6), 617-627.
Loesch, D. Z., Bui, M, Q., Hammersley, E., Schneider, A., Storey, E., Stimpson, P., Burgess, T., Francis, D., Slater, H., Tassone, F., Hagerman, R. J., & Hessl, D. (2015). Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clinical Genetics, 87(2), 173-178.
Protocol ID
121803
Variables
Export Variables| Variable Name | Variable ID | Variable Description | dbGaP Mapping | |
|---|---|---|---|---|
| PX121803000000 | Protocol 121803 - proprietary. Check DCW for more | N/A | ||
Measure Name
Anxiety Disorders Symptoms
Release Date
November 28, 2017
Definition
A questionnaire to assess anxiety disorders, which include a number of different conditions such as panic disorder, generalized anxiety disorder, social phobia, specific phobia, agoraphobia, obsessive-compulsive disorder, and posttraumatic stress disorder (APA, 2000).
Purpose
This measure is used to screen an individual for the presence of anxiety disorders and to assess the severity of underlying symptoms. Anxiety disorders are one of the most prevalent psychiatric conditions occurring in about 18 percent of the population (Kessler et al., 2005). Anxiety disorders may be influenced by genetics and environmental factors and commonly occur with other physical conditions, such as cardiovascular, respiratory, and gastrointestinal disease, as well as with other mental illnesses such as depression and substance abuse disorders (APA, 2000). Furthermore, a significant proportion of pediatric psychiatric patients have anxiety disorders.
Keywords
Psychiatric, phobia
Measure Protocols
| Protocol ID | Protocol Name |
|---|---|
| 121801 | Anxiety Disorders Symptoms - Children - Parent Report |
| 121802 | Anxiety Disorders Symptoms - Children - Self-Report |
| 121803 | Anxiety Disorders Symptoms - Adult |
Publications
There are no publications listed for this protocol.